CRMP2 phosphorylation at the residues targeted by GSK-3β and Cdk5 is higher in human AD brains [41,42,43,44,45] and in the brains of mouse models of AD [43,45,46]. This evidence concerns the gene CDK5 and Alzheimer disease.